Insight Molecular Diagnostics Inc.

IMDX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$18,692$24,287$31,029$8,636
Short-Term Investments$0$0$0$0
Receivables$258$512$3,540$1,613
Inventory$471$693$459$410
Other Curr. Assets$1,968$1,350$1,235$1,100
Total Curr. Assets$21,389$26,842$36,263$11,759
Property Plant & Equip (Net)$2,340$2,524$7,155$2,757
Goodwill$0$0$0$0
Intangibles$14,600$14,600$14,600$14,607
Long-Term Investments$0$1,700$1,700$1,700
Tax Assets$0$0$0$0
Other NC Assets$5,608$4,851$642$4,258
Total NC Assets$22,548$23,675$24,097$23,322
Other Assets$0$0$0$0
Total Assets$43,937$50,517$60,360$35,081
Liabilities
Payables$1,056$1,277$2,279$2,279
Short-Term Debt$1,598$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$5,006$3,835$2,957$2,167
Total Curr. Liab.$7,660$6,652$9,683$7,275
LT Debt$1,529$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$43,944$40,933$38,385$37,711
Total NC Liab.$45,473$42,767$40,459$40,080
Other Liabilities$0$0$0$0
Cap. Leases$3,127$3,374$3,478$3,664
Total Liabilities$53,133$49,419$50,142$47,355
Equity
Pref Stock$0$0$0$0
Common Stock$368,524$367,965$367,387$338,244
Retained Earnings-$377,806-$366,952-$357,210-$350,539
AOCI$86$85$41$21
Other Equity$0$0$0$0
Total Equity-$9,196$1,098$10,218-$12,274
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$43,937$50,517$60,360$35,081
Net Debt-$15,565-$24,287-$31,029-$8,636